Last Updated: May 6, 2026

SOMATULINE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Somatuline patents expire, and what generic alternatives are available?

Somatuline is a drug marketed by Ipsen Pharma and is included in one NDA.

The generic ingredient in SOMATULINE is lanreotide acetate. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the lanreotide acetate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Somatuline

A generic version of SOMATULINE was approved as lanreotide acetate by INVAGEN PHARMS on December 17^th, 2021.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for SOMATULINE?
What are the global sales for SOMATULINE?
What is Average Wholesale Price for SOMATULINE?

Summary for SOMATULINE

US Patents:	0
Applicants:	1
NDAs:	1
Drug Prices:	Drug price information for SOMATULINE
DailyMed Link:	SOMATULINE at DailyMed

Drug patent expirations by year for SOMATULINE

Drug Prices for SOMATULINE

US Patents and Regulatory Information for SOMATULINE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ipsen Pharma	SOMATULINE DEPOT	lanreotide acetate	SOLUTION;SUBCUTANEOUS	022074-001	Aug 30, 2007	AB	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ipsen Pharma	SOMATULINE DEPOT	lanreotide acetate	SOLUTION;SUBCUTANEOUS	022074-002	Aug 30, 2007	AB	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ipsen Pharma	SOMATULINE DEPOT	lanreotide acetate	SOLUTION;SUBCUTANEOUS	022074-003	Aug 30, 2007	AB	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for SOMATULINE

What is the estimated date for somatuline s generic launch in the us?
When can we expect somatuline s generic release in the us?
When does somatuline go generic in the us?
Has the fda approved a generic version of somatuline?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.